Introduction 1
Vitamin D is a steroid hormone with well-known effects on bone metabolism. Children with 2 deficiency may suffer from rickets and adults from osteomalacia. Since several years, however, 3 vitamin D is of interest with respect to the risk of other chronic diseases [1] because it has 4 immunomodulation properties [2] as well as effects on cell differentiation and proliferation [3] , on 5 angiogenesis, but also on blood pressure and glucose tolerance [4] . Therefore, it was suggested that 6 low levels of vitamin D may also increase the risk of death. Cohort studies have shown inverse 7 association of circulating vitamin D concentration with all-cause mortality [5] . Most of these studies 8 indicated a linear association such that highest concentrations were related to the lowest risk. 9 However, in the largest cohort study so far among almost 250,000 Danish men and women, both low 10 (≤ 10 nmol/L) and high (≥ 140 nmol/L) concentrations compared with 50-60 nmol/L were related to 11 increased all-cause mortality [6] . 12 In a recent study, an effect of vitamin D concentration on short term mortality was shown. 13 Thus, the authors hypothesized that vitamin D might rather promote than initiate chronic diseases 14 such as cancer and cardiovascular disease (CVD) [7] . Using data of the Swiss MONICA study, we aimed 15 at analyzing the association between circulating levels of 25- Swiss National Cohort (SNC [8, 9] ) included 3404 participants, from which we derived mortality 1 information up to December 31, 2008 . Of these participants, 188 had to be excluded because they 2 did not provide valid 25-hydroxyvitamin D (25(OH)D) measurements, and 25 were excluded from the 3 analysis due to missing information on one or more other relevant variables, leading to a sample of 4 3191 individuals. At baseline, study participants were 25 to 74 years old. 5
The study participants answered a self-administered questionnaire, which assessed 6 information on demographics, consumption of vitamin-D rich foods (meat, fish, margarine, butter, 7 milk, and yogurt), and proxy measures of sunlight exposure (daily average time spent outdoors; 8 vacation during the past four months). Body mass index (BMI) was calculated as measured body 9 weight divided by squared measured body height [10] . Blood collection and measurement of 10 25(OH)D were described elsewhere [11] . Briefly, a venous blood sample was collected and blood 11 samples were prepared for storage and frozen on the same day. 25(OH)D was measured several 12 months after blood collection by protein-bound assay after extraction (acetonitrile) and purification 13 (Sep-Pak C 18 cartridge; Waters Associates, Milford MA) using the Amersham kit (Aylesbury, 14
Buckinghamshire, UK). The study was conducted according to the ethical guidelines of the Swiss 15
Academy of Medical Sciences. 16 Cox proportional hazards regression models were used to examine the association between 17 25(OH)D concentration and mortality. Time at entry was the examination date and time at exit was 18 date of death or date of censoring, whichever came first. Vitamin D concentration was modeled 19 continuously (per 10 ng/mL) and in quartiles based on the distribution in the cohort. In our models, 20
we also included the following co-variables based on improvement of Akaike's information criterion 21 women (n cancer deaths = 72), most common cancer deaths were lung (16.6%), breast, colorectum 24 (9.7% each), ovaries (8.3%), and pancreas (6.9%); among men (n cancer deaths = 116), most cancer 1 deaths were due to lung (25.8%), prostate (16.4%), colorectum (9.7%), and lymphomas (6.9%). In this sample from a general Swiss population, we observed an inverse association between 5 25(OH)D concentration and all-cause mortality. This was due to decreased cardiovascular mortality in 6 women and decreased mortality due to cancer in men. highest versus lowest concentration of 25(OH)D [5] . In addition to these studies, a study from Israel, 10 including more than 180,000 participants, observed an 85% higher all-cause mortality in participants 11 in the bottom quartile (< 33.8 nmol/L) compared with the top quartile (> 65.2 nmol/L) [7] . The largest 12 study so far, which included almost 250,000 Danish men and women, reported an increased all-cause 13 mortality (RR=2.13, 95% CI 2.02-2. from the US [14] [15] [16] [17] , Finland [18] , Sweden [12] , and Germany [19] and a recent meta-analysis 6 reported a pooled relative risk of 1.42 (95% CI 1.19-1.71) for CVD mortality when comparing the 7 lowest with the highest 25(OH)D categories. [20] . Neither study reported a difference by sex. Other 8 studies found no association between 25(OH)D concentrations and CVD mortality [21] , with one, 9
however, including only men [22] . Interestingly, a non-significant inverse association was observed 10 among women (HR=0.83; 95% CI 0.65-1.07) in NHANES I, but not among men [21] . Our observation 11 can be a chance finding given the small number of cases. However, we had 42 cases of CVD deaths in 12 women and 80 in men and would have expected a statistically significant association in men rather 13 than in women. 14 In contrast to CVD mortality, high circulating concentrations of 25(OH)D were related to 15 decreased cancer mortality only in men, but not in women. Only few studies examined the 16 association between circulating vitamin D and cancer mortality and the results are conflicting. Some 17 studies reported inverse associations between pre-diagnostic vitamin D concentrations and all-18 cancer mortality [12] , mortality from colorectal cancer [23, 24] , prostate cancer [25] , and some 19 studies have shown inverse associations between vitamin D concentration at cancer diagnosis and 20 survival [26, 27] , but not all studies fully support an inverse association [22, 23, 28] . A cohort analysis 21 that relied on vitamin D status indicators only, estimated that cancer mortality might decrease by 22 29% with an increase in 25(OH)D concentration of 25 nmol/L [29] . Other studies looked at cancer 23 incidence instead of mortality. Strongest inverse associations were seen for colorectal cancer 24 incidence, e.g. in EPIC [30] . In our cohort, the most common causes of cancer death among men 1 were prostate, lung, colorectal cancer, and lymphomas, whereas women died from lung, breast, 2 colorectal, ovary, and pancreatic cancer. In contrast to the previous studies, in the MrOS study [22] , 3 lower 25(OH)D levels were related to a decreased risk of cancer among men and in a Swedish cohort, 4 both high and low plasma concentrations were related to increased cancer mortality [12] . 5
Our study has several strengths. The Swiss MONICA cohort is a sample of the general adult 6 population of three Swiss cantons. At baseline, the study assessed a variety of factors potentially 7 influencing the association between 25(OH)D concentration and mortality. Third, our analysis 8 encompasses a follow-up period of up to twenty years, which is longer than in most other studies. 9
One limitation of our study, however, is that vitamin D was only measured once at baseline. Two 10 studies have previously reported moderate [Pearson r = 0.45; [31] ] to high [Pearson r = 0.70; [29] ] 11 correlations between vitamin D measurements three years apart. In the InCHIANTI study [31] , 12 participants with vitamin D levels above and below the median at both blood draws taken three 13 years apart had the lowest and highest rates of mortality, respectively. Consistent with this, those 14 who were above the median at baseline and then decreased to below the median at three years had 15 significantly higher mortality rates than those who were initially below the median and then 16 increased above it at three years. This raises the question whether baseline vitamin D status is 17 representative of one's future vitamin D status and whether hypovitaminosis D is merely a marker of 18 disease and poor outcome [32] . In this respect, it is interesting to note that we observed an 19 association between vitamin D concentration and mortality even after a follow-up period of up to 20 20 years. Excluding the first five years of follow-up in order to reduce the effect of reverse causation, we 21 still observed an inverse association between circulating 25(OH)D and all-cause mortality. A recent 22 meta-analysis has shown that cohort studies with a longer follow-up period tended to have less 23 strong inverse associations between 25(OH)D concentration and mortality than studies with shorter 24 follow-up [33] , and Grant [34] has shown that the correlation coefficient between two vitamin D 25 measurements decreased from 0.7 (1-year difference) to 0.42 for a 14-year difference. However, a 1
Norwegian study compared serum 25(OH)D concentration in participants in 1994 and in 2008 [35] . 
